CD274 and cancer: Although inhibition of PD-1 in patients with tumors is demonstrated to have therapeutic effects, detecting PD-L1 expression via immunohistochemistry would be extremely beneficial in making the clinical determination to use targeted drugs such as nivolumab or pembrolizumab for cancer treatment [14,15].